Fundraising Fox

CND Life Sciences

Scottsdale, US · Founded 2017 · Delaware corporation · 2 known investors

cndlifesciences.com ↗
Biotechin /cnd-life-sciences

Founders & leadership

TL
Todd LevineExecutive Officer, Director
CG
Christopher GibbonsDirector
RJ
Richard J. MorelloExecutive Officer, Director
PH
Peter HarrisExecutive Officer, Director
RF
Roy FreemanDirector
JS
Jack SeaverDirector
EC
Enrique CarrazanaDirector

Investors · 2

BlueStone Venture PartnersTucson · $250K – $1M
Top Corner CapitalBurlingame

Reported raises · per SEC filings

Form D private placements
▶$6.3MraisedAug 2026 · 14 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard J. MorelloExecutive Officer, Director
  • Todd LevineExecutive Officer, Director
  • Peter HarrisExecutive Officer, Director
  • Enrique CarrazanaDirector
  • Christopher GibbonsDirector
  • Jack SeaverDirector
Offering amount
$6.3M
Amount sold
$6.3M
Minimum investment
$25K
First sale
Jun 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8.6MraisedMay 2025 · 38 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard J. MorelloExecutive Officer, Director
  • Todd LevineExecutive Officer, Director
  • Jack SeaverDirector
  • Peter HarrisExecutive Officer, Director
  • Enrique CarrazanaDirector
  • Christopher GibbonsDirector
Offering amount
$9M
Amount sold
$8.6M
Minimum investment
$25K
Sales commissions
$36K
Placement agents
Finalis Securities
First sale
Feb 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedMar 2024 · 22 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Peter HarrisDirector
  • Richard J. MorelloExecutive Officer, Director
  • Enrique CarrazanaDirector
  • Todd LevineExecutive Officer, Director
Offering amount
$6M
Amount sold
$2M
Minimum investment
$25K
First sale
Mar 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedJul 2023 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Enrique CarrazanaDirector
  • Richard J. MorelloExecutive Officer, Director
  • Peter HarrisExecutive Officer, Director
  • Todd LevineDirector
Offering amount
$1.5M
Amount sold
$1.5M
First sale
Jul 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.5MraisedMar 2023 · 26 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Todd LevineExecutive Officer, Director
  • Richard J. MorelloExecutive Officer, Director
  • Peter HarrisExecutive Officer, Director
  • Enrique CarrazanaDirector
Offering amount
$4.5M
Amount sold
$4.5M
First sale
Sep 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.2MraisedNov 2021 · 22 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Peter HarrisDirector
  • Enrique CarrazanaDirector
  • Todd LevineDirector
  • Richard J. MorelloExecutive Officer, Director
  • Roy FreemanDirector
Offering amount
$5M
Amount sold
$4.2M
Minimum investment
$50K
First sale
Oct 2021
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.9MraisedApr 2021 · 20 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Roy FreemanDirector
  • Todd LevineDirector
  • Peter HarrisDirector
  • Richard J. MorelloExecutive Officer, Director
  • Christopher GibbonsDirector
Offering amount
$2.9M
Amount sold
$2.9M
Minimum investment
$50K
First sale
Jan 2021
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.